Press Releases

Receive E-mail Alerts |  RSS Feeds

Date Title   07/10/18 Illumina to Announce Second Quarter 2018 Financial Results on Monday, July 30, 2018 05/29/18 Illumina to Webcast Upcoming Investor Conference Presentations 05/15/18 Illumina Acquires Edico Genome to Accelerate Genomic Data Analysis 05/02/18 Illumina to Webcast Upcoming Investor Conference Presentation 04/24/18 Illumina Reports Financial Results for First Quarter of Fiscal Year 2018 04/13/18 Bristol-Myers Squibb and Illumina Announce Strategic Collaboration to Develop and Commercialize Companion Diagnostics for Bristol-Myers Squibb’s Oncology Immunotherapies 04/10/18 Illumina and Loxo Oncology to Partner on Developing Next-Generation Sequencing-Based Pan-Cancer Companion Diagnostics 04/10/18 Illumina to Announce First Quarter 2018 Financial Results on Tuesday, April 24, 2018 03/12/18 Illumina Names Dr. Phil Febbo Chief Medical Officer 02/27/18 Illumina to Webcast Upcoming Investor Conference Presentation 01/30/18 Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2017 01/26/18 Illumina Awarded $26.7M in Patent Suit Against Ariosa Diagnostics, Inc. 01/16/18 Illumina to Announce Fourth Quarter and Fiscal Year 2017 Financial Results on Tuesday, January 30, 2018 01/08/18 Thermo Fisher Scientific and Illumina Sign Agreement to Provide Research Market Broader Access to Ion AmpliSeq Technology 01/08/18 Illumina Launches iSeq 100 Sequencing System 01/04/18 Illumina and KingMed Diagnostics Partner to Develop Next-Generation Sequencing Technology for Chinese FDA Approval